Skip to main content

Advertisement

Table 1 Baseline clinical and epidemiological characteristics of HIV infected patients

From: Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy

Characteristics All patients HIV groups
Low CD4+ recovery High CD4+ recovery p-value
No. 324 162 162  
Male 264 (81.5%) 138 (85.2%) 126 (77.8%) 0.086
Age (years) 41.0 (34.7; 49.2) 43 (36.4; 51.3) 39.9 (33.8; 46.5) 0.001
Time since HIV diagnosis (years) 1 (1.0; 1.0) 1 (1.0; 2.0) 1 (1.0; 1.0) 0.117
CD4+ cell count at baseline (cells/μL) 105 (41; 159) 93.3 (37.5;147) 114.5 (41.5;165) 0.230
Hepatitis C infection 29 (8.9%) 16 (9.9%) 13 (8.0%) 0.559
Hepatitis B infection 14 (4.3%) 8 (4.9%) 6 (3.7%) 0.585
cART regimen
 PI-based 103 (31.8%) 45 (28.0%) 58 (35.8%) 0.469
 NNRTI-based 165 (51.1%) 88 (54.7%) 77 (47.5%)  
 PI+ NNRTI-based 38 (11.8%) 20 (12.4%) 18 (11.1%)  
 Others 17 (5.3%) 8 (5.0%) 9 (5.6%)  
HIV transmission route
 IDU 51 (17.1%) 30 (20.8%) 21 (13.4%) 0.219
 Homosexual transmission 152 (50.8%) 68 (47.2%) 84 (54.2%)  
 Heterosexual transmission 96 (32.1%) 46 (31.9%) 50 (32.3%)  
  1. IDU intravenous drug users, HIV human immunodeficiency virus, cART combination antiretroviral therapy, PI HIV protease inhibitor, NNRTI non-nucleoside analogue HIV reverse transcriptase inhibitor
  2. Statistical: Values were expressed as absolute number (percentage) and median (percentile 25; percentile 75). Significant differences are shown in bold. p-values were calculated by Chi square and Mann–Whitney tests